tiprankstipranks
Advertisement
Advertisement
Calidi Biotherapeutics Stockholders Approve Key Governance Measures
PremiumCompany AnnouncementsCalidi Biotherapeutics Stockholders Approve Key Governance Measures
2M ago
Calidi receives pre-IND regulatory feedback from FDA for CLD-401
Premium
The Fly
Calidi receives pre-IND regulatory feedback from FDA for CLD-401
2M ago
Calidi Biotherapeutics Amends Warrant in Private Placement
Premium
Company Announcements
Calidi Biotherapeutics Amends Warrant in Private Placement
3M ago
Calidi presents new data on CLD-401 at AACR
PremiumThe FlyCalidi presents new data on CLD-401 at AACR
4M ago
Calidi presents new data on in situ t-cell engagers at AACR
Premium
The Fly
Calidi presents new data on in situ t-cell engagers at AACR
4M ago
Calidi Biotherapeutics Streamlines Board, Enhances Audit Oversight
Premium
Company Announcements
Calidi Biotherapeutics Streamlines Board, Enhances Audit Oversight
5M ago
Calidi announces offering of units, no amount given
PremiumThe FlyCalidi announces offering of units, no amount given
6M ago
Calidi presents data on novel approach to use of BiTEs
Premium
The Fly
Calidi presents data on novel approach to use of BiTEs
6M ago
Calidi to present on approach to bispecific T-cell engagers using RedTail
Premium
The Fly
Calidi to present on approach to bispecific T-cell engagers using RedTail
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100